Did FDA's Pain Med Warning Scare Shionogi Away From Victory?
This article was originally published in PharmAsia News
Executive Summary
Has Victory been turned into defeat? The abrupt and mysterious evaporation of Shionogi's plans to buy Victory Pharma for $150 million is fueling speculation that Japanese pharma got cold feet about the deal, possibly because of FDA's shifting policy on pain products